| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -1.00 | -1.00 | -0.43 | -1.14 |
| Net Changein Cash | 50.00 | 193.00 | -1,045.06 | -815.56 |
| Cash Taxes Paid | 824.00 | 376.00 | 472.65 | 640.98 |
| Net Income/ Starting Line | 2,916.00 | 2,163.00 | 2,368.63 | 3,683.50 |
| Total Cash Dividends Paid | -796.00 | -796.00 | -796.41 | -530.94 |
| Changesin Working Capital | -1,378.00 | -983.00 | -53.84 | -2,011.43 |
| Cashfrom Operating Activities | 1,653.00 | 1,261.00 | 2,459.73 | 1,911.80 |
| Cash Interest Paid | 2.00 | 2.00 | 0.33 | 0.36 |
| Cashfrom Financing Activities | -799.00 | -799.00 | -797.17 | -532.44 |
| Depreciation/ Depletion | 402.00 | 378.00 | 343.18 | 311.51 |
| Other Investing Cash Flow Items Total | 634.00 | 734.00 | -2,234.60 | -1,481.72 |
| Capital Expenditures | -1,438.00 | -1,003.00 | -473.02 | -713.20 |
| period Type | - | - | - | - |
| Non- Cash Items | -287.00 | -297.00 | -198.24 | -71.78 |
| Financing Cash Flow Items | -2.00 | -2.00 | -0.33 | -0.36 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -804.00 | -269.00 | -2,707.62 | -2,194.92 |
Divi's Laboratories Dividend Divi's Laboratories Bonus Divi's Laboratories News Divi's Laboratories AGM Divi's Laboratories Rights Divi's Laboratories Splits Divi's Laboratories Board Meetings Divi's Laboratories Key Metrics Divi's Laboratories Shareholdings Divi's Laboratories Profit Loss Divi's Laboratories Balance Sheet Divi's Laboratories Q1 Results Divi's Laboratories Q2 Results Divi's Laboratories Q3 Results Divi's Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.